BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 38727029)

  • 1. HPV genotyping in clinical samples using long-read single-molecule real-time sequencing.
    Pasquier C; Raymond S; Carcenac R; Demmou S; Ranger N; Nicot F; Izopet J
    J Med Virol; 2024 May; 96(5):e29652. PubMed ID: 38727029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uniplex E6/E7 PCR method detecting E6 or E7 genes in 39 human papillomavirus types.
    Okodo M; Okayama K; Teruya K; Sasagawa T
    J Med Virol; 2018 May; 90(5):981-988. PubMed ID: 29314149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HPV genotype determination and E6/E7 mRNA detection for management of HPV positive women.
    Bruno MT; Ferrara M; Fava V; Rapisarda A; Coco A
    Virol J; 2018 Mar; 15(1):52. PubMed ID: 29587778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [HPV E6 and E7 mRNA combined with HPV 16 and 18 or 45 genotyping testing as a means of cervical cancer opportunistic screening].
    Wang JJ; Dong J; Deng ZX; Wang PF; Zhang XX; Du Y
    Zhonghua Fu Chan Ke Za Zhi; 2019 May; 54(5):301-306. PubMed ID: 31154710
    [No Abstract]   [Full Text] [Related]  

  • 5. Establishment and Application of a Method for High-Risk Human Papillomavirus Genotyping in Cervical Cancer Tissue.
    Zou R; Xie W; Wang H; Wang J; Xiao L; Ji S; Chen X; Zhang L; Xue X; Chen J
    Clin Lab; 2016; 62(6):1075-85. PubMed ID: 27468570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Value of Human Papillomavirus E6/E7 mRNA Detection in Screening for Cervical Cancer in Women Positive for Human Papillomavirus DNA or.
    Han L; Husaiyin S; Zhao F; Rezhake R; Niyazi M
    Clin Lab; 2018 Sep; 64(9):1363-1371. PubMed ID: 30274003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection and genotyping of HPV-DNA through different types of diagnostic platforms in liquid-based cervical-cytology samples.
    Cassani B; Soldano G; Finocchiaro D; Conti S; Bulfamante A; Lemorini G; Bulfamante G
    Pathologica; 2018 Dec; 110(4):294-301. PubMed ID: 30799441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic performance of the E6/E7 mRNA-based Optimygene HR-HPV RT-qDx assay for cervical cancer screening.
    Wang HY; Kim H; Park KH
    Int J Infect Dis; 2019 Jan; 78():22-30. PubMed ID: 30248464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HPV genotyping and E6/E7 transcript assays for cervical lesion detection in an Asian screening population-Cobas and Aptima HPV tests.
    Wong OGW; Tsun OKL; Tsui EY; Chow JNK; Ip PPC; Cheung ANY
    J Clin Virol; 2018 Dec; 109():13-18. PubMed ID: 30368218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical value of HPV E6/E7 and STAT3 mRNA detection in cervical cancer screening.
    Fan Y; Shen Z
    Pathol Res Pract; 2018 May; 214(5):767-775. PubMed ID: 29655523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HPV E6/E7 mRNA versus HPV DNA biomarker in cervical cancer screening of a group of Macedonian women.
    Duvlis S; Popovska-Jankovic K; Arsova ZS; Memeti S; Popeska Z; Plaseska-Karanfilska D
    J Med Virol; 2015 Sep; 87(9):1578-86. PubMed ID: 25880030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the SureX HPV genotyping test for the detection of high-risk HPV in cervical cancer screening.
    Wei B; Mei P; Huang S; Yu X; Zhi T; Wang G; Xu X; Xiao L; Dong X; Cui W
    Virol J; 2020 Nov; 17(1):171. PubMed ID: 33168022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the performance in detection of HPV infections between the high-risk HPV genotyping real time PCR and the PCR-reverse dot blot assays.
    Zhang L; Dai Y; Chen J; Hong L; Liu Y; Ke Q; Chen Y; Cai C; Liu X; Chen Z
    J Med Virol; 2018 Jan; 90(1):177-183. PubMed ID: 28851089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eight-type human papillomavirus E6/E7 oncoprotein detection as a novel and promising triage strategy for managing HPV-positive women.
    Rezhake R; Hu SY; Zhao S; Xu XQ; Zhao XL; Zhang L; Wang Y; Zhang X; Pan QJ; Qiao YL; Zhao FH
    Int J Cancer; 2019 Jan; 144(1):34-42. PubMed ID: 29943809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted next generation sequencing panel for HPV genotyping in cervical cancer.
    Lippert J; Bønløkke S; Utke A; Knudsen BR; Sorensen BS; Steiniche T; Stougaard M
    Exp Mol Pathol; 2021 Feb; 118():104568. PubMed ID: 33171155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of the TypeSeq Assay for Detection of 51 Human Papillomavirus Genotypes by Next-Generation Sequencing.
    Wagner S; Roberson D; Boland J; Yeager M; Cullen M; Mirabello L; Dunn ST; Walker J; Zuna R; Schiffman M; Wentzensen N
    J Clin Microbiol; 2019 May; 57(5):. PubMed ID: 30814267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of oncogenic HPV type-specific viral DNA load and E6/E7 mRNA detection in cervical samples: results from a multicenter study.
    Broccolo F; Fusetti L; Rosini S; Caraceni D; Zappacosta R; Ciccocioppo L; Matteoli B; Halfon P; Malnati MS; Ceccherini-Nelli L
    J Med Virol; 2013 Mar; 85(3):472-82. PubMed ID: 23280876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Aptima and hybrid capture-2 HPV tests and Pap test in the referral population in Japan.
    Kuroki H; Sakamoto J; Shibata T; Takakura M; Sasagawa T
    J Med Virol; 2021 Aug; 93(8):5076-5083. PubMed ID: 33634473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review of the clinical performance of the Aptima HPV assay.
    Haedicke J; Iftner T
    J Clin Virol; 2016 Mar; 76 Suppl 1():S40-S48. PubMed ID: 26614686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aptima HPV E6/E7 mRNA test is as sensitive as Hybrid Capture 2 Assay but more specific at detecting cervical precancer and cancer.
    Ratnam S; Coutlee F; Fontaine D; Bentley J; Escott N; Ghatage P; Gadag V; Holloway G; Bartellas E; Kum N; Giede C; Lear A
    J Clin Microbiol; 2011 Feb; 49(2):557-64. PubMed ID: 21147950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.